Physician profile
Sudhakar R Satti
NPI 1679773881
$536,932.54
in general payments reported to CMS, 2019-2025
23 companies · $73K in 2025
The $73K reported for 2025 was more than what 97% of Neuroradiology providers received nationally (typical 2025 total: $278).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $97K · 2020: $51K · 2021: $52K · 2022: $71K · 2023: $82K · 2024: $110K · 2025: $73K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $177K · Travel and Lodging: $51K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $24K · Food and Beverage: $13K · Gift: $3.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $176,712.16 |
| Travel and Lodging | $51,408.46 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $23,700.00 |
| Food and Beverage | $13,153.35 |
| Gift | $3.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $216,293.39 | 2019-2025 | Emboguard, Trufill, Cerepak Uniform |
| Stryker Corporation | $179,538.81 | 2019-2025 | Surpass Evolve, Neuroform Atlas, Flowgate |
| Penumbra, INC. | $31,032.03 | 2019-2025 | Penumbra System, Benchmark, Smart Coil |
| Rapid Medical Ltd | $28,055.81 | 2023-2025 | Tigertriever 17 Revascularization Device, Comaneci 17 |
| Terumo Medical Corporation | $16,647.30 | 2019-2025 | R2p Misago |
| Imperative Care, INC | $15,859.55 | 2020-2025 | Zoom 88-T Large Distal Platform, Zoom Catheter, Zoom Reperfusion Catheter |
| Balt USA, LLC | $14,463.18 | 2019-2025 | Optima Coil System, Ballast 088 Long Sheath, Eclipse 2l |
| Microvention, INC. | $7,516.66 | 2020-2023 | Sofia 6f-131cm Str |
| Depuy Synthes Sales INC. | $5,330.26 | 2019-2025 | Cerepak Uniform, Embotrap, Trufill |
| Medtronic USA, INC. | $5,094.07 | 2019-2020 | |
| Cordis US Corp. | $4,664.57 | 2022-2025 | Endo, Radial 360, Mynx Control Venous |
| Qapel Medical INC | $3,679.92 | 2021-2022 | |
| Scientia Vascular | $3,157.53 | 2023-2025 | Socrates 38 |
| Cardinal Health 200 LLC | $3,000.00 | 2020 | |
| Depuy Synthes Products, INC. | $1,750.00 | 2022-2023 | Spotlight |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Route 92 Medical, INC. | $466.89 | 2022-2025 | 8f Base Camp Sheath System |
| Medtronic, INC. | $189.29 | 2022 | |
| Boston Scientific Corporation | $71.76 | 2025 | Intracept |
| Inspiremd Ltd | $31.42 | 2025 | Cguard Prime Carotid Stent System |
| Pfizer INC. | $27.55 | 2021 | |
| Abbott Laboratories | $24.75 | 2025 | Xact |
| Cardiva Medical, INC. | $23.71 | 2019 | |
| Siemens Medical Solutions USA, INC. | $14.09 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sudhakar Satti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.